Trial Profile
Clinical Trials Insight: 700020881
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Feb 2007
Price :
$35
*
At a glance
- Drugs Iclaprim (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Arpida
- 13 Feb 2007 New trial record.